The Indian Embassy in Cairo has signed an agreement to procure 300,000 doses of Remdesivir, used in the treatment of the novel coronavirus (COVID-19), from Egypt’s Eva Pharma.
The signing ceremony was attended by Indian Ambassador Ajit Gupte and Riad Armanious, CEO of Eva Pharma. It was held at the Embassy of India in Cairo, with the embassy acting on behalf of India’s Ministry of Health and Family Welfare.
The procurement of the medication will be crucial in India’s fight against the coronavirus, said Ambassador Gupte. Shipment of the vials is expected to begin quickly in the next few days.
On Sunday, Egypt’s Ministry of Health and Population sent three military aircraft to India loaded with large quantities of medical aid.
The Egyptian shipments came as part of the support and solidarity with friendly countries, and implements the directives of President Abdel Fattah Al-Sisi, according to a statement from the spokesperson of the Armed Forces.
The statement added that the shipments were aimed to reduce the burden on the Indian people due to the rapid spread of COVID-19.
India is currently experiencing a second wave of COVID-19, with high rates of infections and deaths amid an acute shortage of medicines, medical supplies, and prevention and protection tools.
